- Home
- FAMI vs XYLO Comparison
FAMI vs XYLO Comparison
Compare FAMI & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- XYLO
- Stock Information
- Founded
- FAMI 2015
- XYLO 1999
- Country
- FAMI China
- XYLO Israel
- Employees
- FAMI N/A
- XYLO N/A
- Industry
- FAMI Packaged Foods
- XYLO
- Sector
- FAMI Consumer Staples
- XYLO
- Exchange
- FAMI Nasdaq
- XYLO NYSE
- Market Cap
- FAMI 3.1M
- XYLO 3.1M
- IPO Year
- FAMI 2018
- XYLO N/A
- Fundamental
- Price
- FAMI $0.16
- XYLO $5.19
- Analyst Decision
- FAMI
- XYLO
- Analyst Count
- FAMI 0
- XYLO 0
- Target Price
- FAMI N/A
- XYLO N/A
- AVG Volume (30 Days)
- FAMI 4.4M
- XYLO 13.7K
- Earning Date
- FAMI 03-21-2025
- XYLO 04-21-2025
- Dividend Yield
- FAMI N/A
- XYLO N/A
- EPS Growth
- FAMI N/A
- XYLO N/A
- EPS
- FAMI N/A
- XYLO N/A
- Revenue
- FAMI $64,131,332.00
- XYLO $57,642,000.00
- Revenue This Year
- FAMI N/A
- XYLO $16.76
- Revenue Next Year
- FAMI N/A
- XYLO $5.71
- P/E Ratio
- FAMI N/A
- XYLO N/A
- Revenue Growth
- FAMI N/A
- XYLO N/A
- 52 Week Low
- FAMI $0.15
- XYLO $2.70
- 52 Week High
- FAMI $0.94
- XYLO $8.83
- Technical
- Relative Strength Index (RSI)
- FAMI 24.69
- XYLO 62.11
- Support Level
- FAMI $0.23
- XYLO $4.51
- Resistance Level
- FAMI $0.29
- XYLO $5.66
- Average True Range (ATR)
- FAMI 0.02
- XYLO 0.42
- MACD
- FAMI -0.01
- XYLO 0.12
- Stochastic Oscillator
- FAMI 9.79
- XYLO 77.07
About FAMI Farmmi Inc.
Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.